To Determine the Effect of Phaseolean on Glycemic Response to Carbohydrate Rich Meal in Healthy Adult Human Participants

ConditionHealthy
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-45
SponsorNovoBliss Research Pvt Ltd

About this trial

This is an Open-Label, Randomized, Three-Way, Three-Arm, Crossover, Balance Study to Evaluate the Effect of Phaseolean on Glycemic response to carbohydrate rich meals in Healthy Adult Participants Using an In Vivo Method.

Eligibility criteria

Qualifiers

None

Disqualifiers

Participant has any known food allergy or intolerance to any food or beverages.

Participant is taking any medication in the past one week.

Participants should not be taking any medications known to affect glucose tolerance (excluding oral contraceptives) - stable doses of oral contraceptives, acetylsalicylic acid, thyroxin, vitamins and mineral supplements or drugs to treat hypertension or osteoporosis are acceptable

Participants should not have any known food allergy or intolerance

Trial design

Treatments tested in this trial

  • Phaseolean (White Kidney Bean Extract) 1000 milligrams
  • Phaseolean (White Kidney Bean Extract) 2000 milligrams
  • Anhydrous Glucose Powder
  • Plain white bread

Treatment groups

12 Participants
are divided into 4 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

NovoBliss Research Pvt Ltd

Lead sponsor

Ambe Phytoextracts Pvt. Ltd

Collaborator